)
Deepak Korgaonkar boasts of an impressive 25-year experience on tracking and writing market stories based on extensive research and analysis of stocks/ sectors. He also specialises in reporting real-time stock market trends and impact stories. He holds a postgraduate degree from Mumbai University.
Deepak Korgaonkar boasts of an impressive 25-year experience on tracking and writing market stories based on extensive research and analysis of stocks/ sectors. He also specialises in reporting real-time stock market trends and impact stories. He holds a postgraduate degree from Mumbai University.
Currently, Rakesh Jhunjhunwala and his family's net worth in listed companies stands at Rs 8,517 crore, compared to Rs 8,388 crore as on March 31, 2020.
According to the term sheet, an over 133 million shares - 5.7 per cent of the total equity shares - are being offered in the range of Rs 1,850-1,950 to investors through a special block window.
Analysts, however, do caution against the rich valuation the pharma index and the stocks are trading at
Thus far in CY20, 20 companies have announced buyback of their shares, of which, 14 firms have proposed to buyback from open market route
Among sectors, stocks of banks, cement, chemicals, engineering, agro chemicals, automobiles, fast moving consumer goods (FMCG), sugar, aviation have seen increase in delivery-based trades.
Of the 143 stocks from the F&O segment, 10 have seen their market price more than halve in the March F&O series.
Rakesh Jhunjhunwala and family, the big bull of the equity markets, have lost Rs 4,558 crore in CY20 so far, with the value of their investments slipping below Rs 10,000 crore
The value of insurer's holdings in listed companies at the end of December 2019 quarter stood at Rs 6.02 trillion
The stock saw a weak debut due to prevailing market condition as the uncertainty regarding the effect of the coronavirus epidemic continued to keep investor sentiment in check.
Among sectors, refineries, financials including banks and information technology (IT) have seen more than Rs 1-trillion market-cap erosion in the past six sessions.
With an m-cap of Rs 31,744 crore at 12:05 pm, IRCTC stood at 96th position in the overall market capitalisation ranking, the BSE data shows.
S&P BSE SmallCap index has climbed over 6 per cent in January so far, outperforming the benchmark S&P BSE Sensex.
In CY18, the midcap and smallcap indices had tanked 13 per cent and 24 per cent
Domestic mutual funds pumped in Rs 52,850 crore in equities during CY19
Of the 13 companies that got listed in 2019, eight have outrun the IPO index by gaining over 38 per cent against their respective issue price
In the past seven trading days, RIL has outperformed the market by gaining 8 per cent, after Reliance Jio, the telecom arm of the company, said it will increase tariffs in next few weeks.
So far this calendar year, FPIs' stakes in SBI Life, Insurance ICICI Lombard and HDFC Life have risen by 18.85, 8.62 and 7.71 percentage points, respectively, since the December 2018 quarter
At the global level, trade war tussle, monetary policy of major central banks and oil prices, analysts feel, are the factors that will dictate market direction
Out of 11 companies that got listed in 2019, nine have outrun the market by gaining more than 10 per cent against their respective issue price
The state-owned company raised Rs 645 crore through its initial public offer (IPO).